News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ALIGOS THERAPEUTICS reported a net income of USD -1.504 million for the second quarter. This financial update provides a key insight into the company's recent performance.
Align Technology reported Q2 2026 net revenues of $1,056.2 million, up 4.3% year-over-year, driven by strong Clear Aligner revenues. The company also announced plans to invest $200 million in a new manufacturing facility in Hyderabad, India, expected to commence operations in 2027. This expansion …
ALIGN TECHNOLOGY INC (ALGN) reported its 2026 quarterly results with a revenue of $1.06 billion, an increase of 4.3% year over year, despite a decline in net income and diluted EPS. The company's Clear Aligner revenues saw an 8.2% rise, driven by higher case …
Alight, Inc.'s CFO, Stephen Andrew Lasher, was granted 87,500 performance stock units on August 3, 2026. These units are contingent on stock-price performance hurdles through December 31, 2030, and service-based conditions, with vesting in up to 25% increments. This transaction follows a 1-for-20 reverse …
Alight, Inc. CEO Rohit Verma was granted 80,000 Performance Stock Units on August 3, 2026, which are contingent rights to Class A Common Stock. These units will vest in increments of up to 25% based on stock price performance hurdles and service-based conditions until …
Align Technology's Q2 results showed growth in Clear Aligner volumes and stable North American performance, with strong international expansion. Despite this, management noted softness in the Systems and Services segment due to shifts towards lower-cost scanner models. Analysts focused on how Align maintains high …
This article first appeared on GuruFocus. Revenue: $511 million in Q2 2026, a decrease of approximately 3% year-over-year. Recurring Revenue: $471 million, down 4.3% compared to Q2 2025. Project Revenue: $40 million, up 11% year-over-year. Adjusted Gross Profit: $176 million, down $29 million from …
Alignment Healthcare, Inc. (ALHC), a healthcare plans provider for seniors, shows potential for a 69% upside according to analyst ratings. Despite recent stock volatility and a bearish short-term technical outlook, the company boasts robust revenue growth and a strong return on equity. Its focus …
Alight, Inc. (ALIT) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $2 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Alight (NYSE:ALIT) Beats Q2 CY2026 Sales Expectations But Stock Drops On Weak Guidance Human capital management provider Alight (NYSE:ALIT) reported revenue ahead of Wall Street's expectations in Q2 CY2026, but sales fell by 3.2% year on year to $511 million. On the other hand, …
Alight, Inc. reported its second quarter 2026 results, with revenue reaching $511 million and year-to-date cash from operations at $152 million. Despite a slight decrease in revenue compared to the prior year, the company exceeded expectations for total revenue and adjusted EBITDA, driven by …
Alignment Healthcare (ALHC) is facing scrutiny due to a whistleblower lawsuit alleging misclassification of operating expenses, impacting its adjusted EBITDA. Despite a significant short-term stock price decline, a narrative suggests the company is 41.6% undervalued with a fair value of $24.92, based on aggressive …
Citi analyst Daniel Grosslight reiterated a Buy rating for Align Tech (ALGN) with a price target of $240.00. This follows a similar Buy rating from Barclays and comes despite a Sell rating from Bank of America Securities. Align Tech reported a quarterly revenue of …
Alight's established leave solutions are fully powered by Alight Worklife®, where employees and employers benefit from a more connected and confident leave experience DEERFIELD, Ill., August 04, 2026--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today …
ALGN Q2 Deep Dive: Clear Aligner Volumes Grow, Guidance Flags Scanner Mix Shift Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street's revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter's revenue …
Sharemaestro market context Price above Trend Line 52 weeks +22.6% · Next-week setup negative 39.0%JP Morgan has lowered its target price for ALIGNMENT HEALTHCARE INC from $26 to $22. This news was reported by Reuters on August 4, 2026. The article provides a brief update on the analyst rating change for the healthcare company.
Align Technology (ALGN) released new guidance for Q3 and full-year 2026, alongside Q2 results and a buyback update, leading to mixed investor sentiment. Despite a 1-year total shareholder return of 23.8%, the 3-year and 5-year returns have significantly declined, suggesting long-term momentum has faded. …
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following allegations of accounting irregularities that "artificially inflated" the company's financial results. A former executive filed a whistleblower complaint claiming millions in operating expenses were misclassified as capital expenditures, leading …
The provided content is a privacy consent page from Yahoo and does not contain any article text about Alignment Healthcare (ALHC). Therefore, it's impossible to summarize why the company might be ripe for a turnaround based on the given information. The content primarily focuses …
Raymond James downgraded Alignment Healthcare (NASDAQ:ALHC) to Outperform from Strong Buy and lowered its price target due to concerns about earnings visibility as the company expands into new markets. While Q2 2026 earnings beat expectations and the full-year guide was raised, increased investment spend …
Alight (ALIT) Reports Q2: Everything You Need To Know Ahead Of Earnings Human capital management provider Alight (NYSE:ALIT) will be reporting earnings this Tuesday after market hours. Here's what to look for. Alight beat analysts' revenue expectations last quarter, reporting revenues of $534 million, …
Align Technology announced plans to appoint three new independent directors and increase its 2026 share repurchase commitment to between $400 million and $500 million, following discussions with Elliott Investment Management. The company will also conduct a comprehensive strategic review to strengthen commercial execution and …
Alignment Healthcare Inc. (ALHC) stock dropped significantly by 18.66% following a whistleblower lawsuit alleging the company misclassified $8–$10 million in expenses as capital expenditures to inflate Adjusted EBITDA. Several law firms have initiated investigations into potential securities law violations, posing material regulatory and governance …
Analysts from Bank of America Securities have issued bullish sentiments on three healthcare companies: Stryker (SYK), Alignment Healthcare (ALHC), and McKesson (MCK). Stryker received a Buy rating with a $380.59 price target, implying a 15.3% upside. Alignment Healthcare also garnered a Buy rating and …
Alignment Healthcare (ALHC) Stock Trades Down, Here Is Why What Happened? Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC) fell 14.8% in the afternoon session after the company revealed plans to reinvest profits, which will lower its expected earnings for the second half of …
ALHC Q2 Deep Dive: Investments in Clinical Innovation and Member Growth Drive Mixed Market Response Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 31.6% year on year to $1.34 billion. The company expects …
Alignment Healthcare (ALHC) experienced a significant stock drop despite showing improved Q2 2026 earnings, including a 32% revenue increase and better adjusted medical benefit and EBITDA margins. The market's reaction is attributed to ongoing legal risks, such as a whistleblower lawsuit and securities investigations, …
Align Technology Inc. (ALGN) shares fell by 2.45% on Friday, closing at $169.16. This underperformance occurred despite a positive trading session for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both seeing gains. This marks the second consecutive day …
Vanguard Portfolio Management LLC has reported a significant stake in Alignment Healthcare Inc. (ALHC), holding 11,874,585 shares, which represents 5.74% of the outstanding common stock. This disclosure, made via a SCHEDULE 13G filing, indicates Vanguard has sole dispositive power over all these shares and …
Alignment Healthcare reported a significant 31.6% revenue increase to $1.34 billion in Q2 2026, exceeding analyst expectations. The company attributed this strong performance to its new AI-powered stratification model, which helps predict hospitalizations and optimize care. Alignment also raised its 2026 forecast, projecting membership …
Search by ticker symbol or company name and select a result to open its chart.